V. Galata

发表

Prioritizing and selecting likely novel miRNAs from NGS data

J. Haas, A. Keller, B. Meder, 2015, Nucleic acids research.

What makes a blood cell based miRNA expression pattern disease specific? - A miRNome analysis of blood cell subsets in lung cancer patients and healthy controls

Christina Backes, Eckart Meese, Andreas Keller, 2014, Oncotarget.

miRNAs can be generally associated with human pathologies as exemplified for miR-144*

Sabine C. Mueller, Christina Backes, Benjamin Meder, 2014, BMC Medicine.

The sncRNA Zoo: a repository for circulating small noncoding RNAs in animals

Hans-Peter Lenhof, A. Keller, G. Gasparoni, 2019, Nucleic acids research.

Integrating Culture-based Antibiotic Resistance Profiles with Whole-genome Sequencing Data for 11,087 Clinical Isolates

Andreas E. Posch, C. Laczny, A. Franke, 2018, bioRxiv.

PathoFact: a pipeline for the prediction of virulence factors and antimicrobial resistance genes in metagenomic data

A. Heintz‐Buschart, P. May, C. Laczny, 2020, bioRxiv.

Secretion and Immunogenicity of the Meningioma-Associated Antigen TXNDC16

A. Keller, M. Menger, C. Backes, 2014, The Journal of Immunology.

Clinical Resistome Screening of 1,110 Escherichia coli Isolates Efficiently Recovers Diagnostically Relevant Antibiotic Resistance Biomarkers and Potential Novel Resistance Mechanisms

Andreas E. Posch, A. Keller, R. Müller, 2019, Front. Microbiol..

Gene amplification in mesenchymal stem cells and during differentiation towards adipocytes or osteoblasts

U. Fischer, A. Keller, E. Meese, 2017, Oncotarget.

Large-scale validation of miRNAs by disease association, evolutionary conservation and pathway activity

R. Balling, R. Krüger, Hans-Peter Lenhof, 2018, RNA biology.